Clinical Trial Update: The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

View source ↗

Summary

Clinical trial update on the effectiveness of paritaprevir/ritonavir-ombitasvir ± dasabuvir ± ribavirin in France for chronic hepatitis C; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ribavirin (ribavirin)
• paritaprevir/ritonavir-ombitasvir (paritaprevir/ritonavir-ombitasvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2019-06-17